3/19
08:04 am
dmac
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) had its price target raised by analysts at HC Wainwright from $7.00 to $10.00. They now have a "buy" rating on the stock.
Neutral
Report
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) had its price target raised by analysts at HC Wainwright from $7.00 to $10.00. They now have a "buy" rating on the stock.
3/17
04:30 pm
dmac
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results
High
Report
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results
3/17
08:07 am
dmac
Insider Stock Buying Reaches US$9.00m On DiaMedica Therapeutics [Yahoo! Finance]
Medium
Report
Insider Stock Buying Reaches US$9.00m On DiaMedica Therapeutics [Yahoo! Finance]
3/11
08:23 am
dmac
DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025
Low
Report
DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025
2/24
08:41 am
dmac
DiaMedica Therapeutics Appoints Daniel J. O'Connor to the Board of Directors [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics Appoints Daniel J. O'Connor to the Board of Directors [Yahoo! Finance]
2/24
08:30 am
dmac
DiaMedica Therapeutics Appoints Daniel J. O’Connor to the Board of Directors
Low
Report
DiaMedica Therapeutics Appoints Daniel J. O’Connor to the Board of Directors
2/20
08:51 am
dmac
DiaMedica Therapeutics Announces Publication of DM199's Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics Announces Publication of DM199's Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke [Yahoo! Finance]
2/20
08:15 am
dmac
DiaMedica Therapeutics Announces Publication of DM199’s Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke
Low
Report
DiaMedica Therapeutics Announces Publication of DM199’s Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke
2/10
04:15 pm
dmac
DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Low
Report
DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
1/29
11:04 pm
dmac
DiaMedica Therapeutics: Interesting Work In Treating Ischemic Stroke [Seeking Alpha]
Low
Report
DiaMedica Therapeutics: Interesting Work In Treating Ischemic Stroke [Seeking Alpha]